Partnership the power behind lung disease treatment

UWA. Australia: Help may be on its way for sufferers of lung fibrosis - a condition sometimes caused by exposure to asbestos but one that sometimes appears without any known stimulus. There is limited treatment for lung fibrosis and sadly patients usually only live for three to five years after diagnosis of this extremely debilitating condition.
A new partnership between The University of Western Australia and stem cell and regenerative medicine company Cynata Therapeutics Ltd may change all that, with a study that will test the potential of Cymerus^TM mesenchymal stem cells (MSCs) in a pre-clinical model of the disease.